TSX:BHC (Bausch Health Companies Inc.)

About BHC

Bausch Health Companies Inc. is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries. Five pillars or guiding principles represent the foundation on which we are realizing our mission as an organization: People Quality Health Care Outcomes Customer Focus Innovation and Efficiency.
  • Bausch Health Companies Inc. (TSX: BHC) Latest News

    The Motley Fool
    Investing

    Why Bill Ackman Should Give Up on Valeant Pharmaceuticals Intl Inc.

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) reported a horrible quarter, and the stock responded by dropping. Bill Ackman still believes in…

    Read more »

    Investing

    3 TSX “Loser” Stocks to Bet on

    A total of 32 TSX stocks are down by more than 5% year-to-date, including Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX), the…

    Read more »

    Investing

    Long-Term Investors: Valeant Pharmaceuticals Intl Inc. Looks to Ease Debt Burden

    Valeant Pharmaceuticals Intl Inc.'s (TSX:VRX)(NYSE:VRX) sale of its Salix drug business has the potential for great long-term gains for investors…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. Drops After Q3 Results Disappoint

    Troubles continue for Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) as the company posts worse than expected results.

    Read more »

    The Motley Fool
    Investing

    Should You Buy Valeant Pharmaceuticals Intl Inc. After its 22% Plunge?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) took a huge hit in its latest earnings report, and the stock responded by dropping…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: Should You Try to Catch This Falling Knife?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) just reminded investors that cheap stocks can get a lot cheaper very quickly.

    Read more »

    The Motley Fool
    Dividend Stocks

    3 Canadian Stocks to Buy in a Donald Trump World

    A Trump presidency is good news for TransCanada Corporation (TSX:TRP)(NYSE:TRP), Barrick Gold Corp. (TSX:ABX)(NYSE:ABX), and one other stock.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. Is in Trouble Again: Down 25%

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is a lottery ticket with huge upside and downside potential.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals International Inc. Q3 Earnings Preview: It’s Gonna Be Ugly

    What to expect from the market's most beaten-up stock, Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) next Tuesday.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. in Talks to Sell $10 Billion Division: What Now?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) had big news on Tuesday. Investors need to be patient and wait.

    Read more »

    The Motley Fool
    Investing

    The Real Reason Why Bill Ackman Still Holds Valeant Pharmaceuticals Intl Inc.

    Valeant Pharmaceutical Intl Inc. (TSX:VRX)(NYSE:VRX) has fallen so much that there might be some value to be had. Bill Ackman…

    Read more »

    The Motley Fool
    Investing

    Why Valeant Pharmaceuticals Intl Inc. Is the Best Contrarian Pick for 2017

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is a newly minted value stock, which offers an interesting entry point for long-term investors.…

    Read more »